Tag: SGLT-2 inhibitors

A meta-analysis of ten studies suggests GLP-1 receptor agonists and SGLT-2 inhibitors reduce major adverse cardiovascular events in patients with ...

A comprehensive clinical review details how specialized preoperative evaluation and targeted comorbidity optimization significantly improve postoperative outcomes and reduce perioperative ...

A retrospective study in Pakistan found that liraglutide combined with SGLT-2 and DPP-4 inhibitors significantly improved glycemic control and weight ...

A comprehensive literature review evaluates empagliflozin's efficacy, safety, and cardiorenal benefits in patients with and without diabetes.

A systematic review and meta-analysis finds an association between SGLT-2 inhibitor use and lower incident hepatocellular carcinoma in type 2 ...

A new review maps how oxidative stress and inflammation drive diabetic nephropathy and highlights biomarkers and drugs for earlier detection ...

A systematic review of nine randomized studies finds exploratory biomarker and neuroimaging signals for GLP-1 receptor agonists and SGLT-2 inhibitors ...

A randomized crossover trial found that the SGLT-2 inhibitor ertugliflozin lowered dexamethasone-induced hyperinsulinemia in healthy horses by 30 to 45 ...

The recent narrative review conducted by DeLacey, Dieguez, and Bensignor delves into the intricate landscape of glycemic management in youth ...